![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 37, 25971-25974, September 10, 1999
§,
§,
,
,
From the A sequence motif,
GXRXGGGXGD, located in the putative
channel-forming domain, is conserved in all known ryanodine receptors and inositol 1,4,5-trisphosphate receptors. The functional significance of this conserved region was investigated by using site-directed mutagenesis together with functional assays consisting of
Ca2+ release measurements, [3H]ryanodine
binding, and single channel recordings in planar lipid bilayers. We
report here that single point mutations introduced into this region of
the mouse cardiac ryanodine receptor reduce or abolish high affinity
[3H]ryanodine binding. Single channel analysis revealed
that a single substitution of alanine for glycine 4824 within this
region reduced the single channel conductance by 97%, from 798 picosiemens (pS) for the wild type channel to 22 pS. The G4824A mutant
channel was modulated by Ca2+, Mg2+, ATP,
caffeine, ruthenium red, and ryanodine. Co-expression of the wild type
and G4824A mutant proteins produced single channels that have
intermediate unitary conductances of 516, 256, 176, and 60 pS. These
data suggest that this conserved region constitutes an essential part
of the ryanodine binding site and the channel conduction pathway of the
ryanodine receptor.
Ryanodine receptors
(RyRs)1 are members of a
superfamily of intracellular Ca2+ channels that include the
inositol 1,4,5-trisphosphate receptors (IP3Rs). These
channels play an essential role in intracellular Ca2+
signaling by virtue of releasing Ca2+ from the lumen of
sarco(endo)plasmic reticulum to the cytosol of muscle and non-muscle
cells (1, 2).
RyR is a homotetrameric structure composed of four identical subunits,
each having ~5000 amino acids. Sequence analysis reveals that
one-fifth of the COOH terminus of the molecule is likely to form the
channel conducting pore. The remaining ~4000 amino acid residues
apparently constitute the cytoplasmic "foot" domain (3-7). A
truncated RyR in which the foot domain has been deleted has been shown
to function as a Ca2+ release channel. The truncated RyR
channel was still regulated by Ca2+, was modified by
ryanodine, and exhibited a single channel conductance similar to that
of the full-length RyR (8). These studies indicate that the sites for
Ca2+ activation and ryanodine binding, and the ion
conduction pathway are located within the COOH-terminal ~1000 amino
acid residues. A glutamate residue located in the putative
transmembrane sequence M2 has recently been identified as the
Ca2+ sensor of RyR (9). The locations of the ryanodine
binding site and the pore-forming segment of RyR, however, have yet to be defined.
RyRs and IP3Rs share some sequence homology, in particular
in the COOH-terminal channel-forming domain (10). Considering their
sequence homology and similar conduction properties (11-13), RyRs and
IP3Rs are likely to share similar structural features in
the channel pore. A hydrophobic region between the M5 and M6 transmembrane sequences of the mouse type 1 IP3R has been
proposed to be the pore-forming region (14). The equivalent region in RyR, corresponding to the M9 transmembrane sequence proposed by Zorzato
et al. (15), is also hydrophobic. Sequence alignment of
these regions reveals a GXRXGGGXGD
motif that can be found in all known RyRs and IP3Rs (Fig.
1). To investigate its role in RyR function, we have introduced point
mutations into this highly conserved region and examined the functional
consequences of these point mutations. Our data indicate that this
region is critical for ryanodine binding and ion conduction and
probably constitutes the pore-forming segment of RyRs.
Materials--
Ryanodine was obtained from Calbiochem.
[3H]Ryanodine was from NEN Life Science Products.
Monoclonal antibody 34C was a generous gift from Dr. John L. Sutko
(16).
Cloning of the Mouse Cardiac RyR cDNA--
Total RNA from
mouse heart tissue, isolated by the method of Chomczynski and Sacchi
(17), was used to generate first strand cDNA using the SuperScript
Preamplification System (Life Technologies, Inc.) with random primers.
Using degenerate primers designed on the basis of the reported cDNA
sequences of the rabbit (18, 19) and human (20) cardiac RyR, we
obtained six short PCR fragments corresponding to nucleotides
1171-1661, 3286-3821, 5689-6256, 11029-11646, 13366-13599, and
13473-14919 of the mouse cardiac RyR (mRyR2) cDNA. These cDNA
fragments were then used as probes to screen a mouse cardiac cDNA
library. Four overlapping clones, corresponding to nucleotides
5'-UTR-6486, 1891-8268, 7602-13,359, and 12,991-3'-UTR, covering the
entire coding region and part of the 5'- and 3'-untranslated regions of
the mRyR2, were obtained. These overlapping clones were used to
construct the full-length mRyR2 cDNA in the expression vector
pCDNA3 (Invitrogen) for functional expression studies.
Site-directed Mutagenesis--
Point mutations were carried out
by the overlap extension method (21) using the PCR. The NruI
(14,237)-NotI (vector) cDNA fragment that contains the
3' end of the mRyR2 cDNA was subcloned into the pBluescript vector
and was used as a template for site-directed mutagenesis. PCR products
were subcloned into pBluescript and the sequence of each PCR clone was
confirmed by DNA sequencing. The NruI
(14,237)-NotI (vector) fragment was removed from the PCR
clone and subcloned into the full-length mRyR2 cDNA. Transfection of HEK293 cells were carried out using Ca2+ phosphate precipitation.
Ca2+ Release Measurements--
Free cytosolic
Ca2+ concentration in transfected HEK293 cells was measured
with the fluorescence Ca2+ indicator dye fluo-3 as
described previously (9).
[3H]Ryanodine Binding--
Equilibrium
[3H]ryanodine binding to cell lysates was carried out
using the method described by Du et al. (22).
RyR Purification and Single Channel Recordings--
Recombinant
wild type and mutant mRyR2 proteins were purified from cell lysates by
sucrose density gradient centrifugation as described previously (23).
Single channel recordings were carried out using CHAPS-solubilized and
sucrose density gradient-purified wild type and mutant recombinant
mRyR2 proteins as reported previously (23). Free Ca2+
concentrations were calculated using the computer program of Fabiato
and Fabiato (24).
We first investigated the functional consequences of single point
mutations in the putative pore-forming segment (Fig.
1) by measuring caffeine-induced
Ca2+ release in HEK293 cells transfected with the wild type
and various mutant cDNAs. Addition of 2 mM caffeine
resulted in an increase in the fluo-3 fluorescence in cells transfected
with the wild type and all mutant cDNAs, but not in cells
transfected with the vector DNA (Fig.
2a). These data demonstrate
that all mutants can function as Ca2+ release channels. To
further characterize these mutants, we carried out
[3H]ryanodine binding. Fig. 2b shows that
mutations at R4822, G4825, G4828, and D4829 reduced or abolished high
affinity [3H]ryanodine binding, while caffeine-induced
Ca2+ release from these mutants was comparable with that
from the wild type. On the other hand, mutation at G4824 retained
[3H]ryanodine binding, but decreased caffeine-induced
Ca2+ release. Mutations at G4820 and G4826 reduced
caffeine-induced Ca2+ release and abolished
[3H]ryanodine binding. It should be noted that the levels
of expression of the wild type and mutant RyR proteins were similar as
revealed by immuno blotting (Fig. 2b). These data indicate
that this conserved region is critical for ryanodine binding and
channel function.
Ryanodine binds to RyRs in an open state with high affinity. The
binding of ryanodine modifies channel gating and ion conduction and
reduces single channel conductance of RyRs (3-7, 25). The significance
of this region in ion conduction was examined by determining the effect
of these mutations on single channel conductance. Fig.
3a shows single channel
recordings of the wild type and mutant G4824A channels after
incorporating into planar lipid bilayers at different holding
potentials. The unitary conductance of the mutant G4824A channel,
determined in symmetrical 250 mM KCl, was 22 ± 1.1 pS
(n = 4), compared with 798 ± 17 pS
(n = 3) for the wild type channels. Thus, the G4824A
mutation reduced the single channel conductance of mRyR2 by 97%. To
examine whether the G4824A mutant channel is still sensitive to
modulators of RyR, we assessed the effects of various ligands on single
channel activity and [3H]ryanodine binding. The mutant
channel was activated by ATP and caffeine, was inhibited by
MgCl2, and was modified by ryanodine (Fig. 3b).
[3H]Ryanodine binding to mutant G4824A was also activated
by ATP, caffeine, and Ca2+ and was inhibited by
MgCl2, ruthenium red, and EGTA (Fig. 3c). A similar extent
of modulation by these ligands on [3H]ryanodine binding
(Fig. 3c) and single channel activity (not shown) was also
observed with the wild type channel. Thus, the specific effect of
G4824A mutation on single channel conductance and the critical role of
residues flanking this glycine in high affinity ryanodine binding
suggest that this region is involved in the formation of the channel
conducting pore.
Cardiovascular Research Group,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
A schematic diagram of transmembrane domains
of RyR and IP3R. Ten transmembrane sequences (M1 to
M10) have been predicted for RyR (15) and six (M1 to M6) for
IP3R (14). The location of each transmembrane segment is
depicted by a solid box. The shaded box indicates
the location of the putative pore-forming segment (P) in
IP3R. The amino acid sequence of this putative pore-forming
segment and the sequence of the equivalent region of mRyR2 are shown by
single letter amino acid codes. The solid circles indicate
amino acid residues that are conserved in all known RyRs and
IP3Rs and were mutated in this study.

View larger version (30K):
[in a new window]
Fig. 2.
Effects of point mutations on intracellular
Ca2+ release in transfected HEK293 cells
(A) and on [3H]ryanodine binding
(B). A, HEK293 cells were transfected
with 6 µg of wild type (WT) cDNA; 6 µg of mutant
(G4820A, R4822A, G4824A, G4825A, G4826A, G4828A, or D4829A) cDNA;
or 6 µg of pCDNA3 vector DNA. Fluorescence intensity of fluo
3-loaded cells was measured before and after addition of 2 mM caffeine (solid circles). B,
[3H]ryanodine binding was carried out in the presence of
0.5 mM EGTA and 0.8 mM CaCl2. Data
shown are mean ± average error from three separate experiments.
The bottom panel shows an immunoblot (23) of cell lysates
(10 µl) prepared form HEK293 cells transfected with 12 µg of wild
type (WT) cDNA, various mutant cDNAs, or pCDNA3
using the anti-RyR monoclonal antibody 34C.

View larger version (40K):
[in a new window]
Fig. 3.
Effects of G4824A mutation on single channel
function and [3H]ryanodine binding. a,
single channel activities of the wild type (WT)
(A) and G4824A mutant (B) mRyR2 channels were
recorded in a symmetrical recording solution containing 250 mM KCl and 25 mM Hepes (pH 7.4). The holding
potentials are shown on the left, and base lines are
indicated by a short line to the right of each
current trace. Current-voltage (I-V) relationships of the wild type
(C) and G4824A mutant (D) are shown.
b, a single mutant G4824A channel was inhibited by the
addition of 100 µM EGTA (cis) (not shown),
indicating that the channel was incorporated into the bilayer with its
cytoplasmic side facing the cis chamber. All subsequent
additions were then made to the cis (cytoplasmic) chamber.
Single channel current recordings in the presence of 127 nM
free Ca2+, and after sequential additions (cis)
of 2 mM ATP and 2 mM caffeine were made from
the same channel. Current recordings in the presence of 10 µM ryanodine were obtained from a different channel.
Single channel activities shown in E (control) and
F (after addition of 2 mM MgCl2)
were recorded in the presence of 200 nM free
Ca2+. The open probability (Po) at
each condition is indicated on the top of each panel. The holding
potential was +80 mV. C, [3H]ryanodine binding
to the wild type and G4824A mutant mRyR2 was carried out in the
presence of 120 nM free Ca2+ (Cont)
or plus 2.5 mM ATP, 2.5 mM caffeine, 5 mM MgCl2, 30 µM ruthenium red,
2.5 mM EGTA, or 150 µM CaCl2.
Data shown are mean ± average error from three separate
experiments.
In potassium channels, the ion conduction pathway is formed by the
pore-forming segments of each subunit (26, 27). To determine whether
this is also the case for RyR, we co-expressed the wild type and mutant
G4824A cDNA in a 1:1 ratio in HEK293 cells and determined the
unitary conductance of each single channel observed. We expected that
co-expression of the wild type and mutant channel would result in the
formation of hybrid channels that contained different ratios of wild
type and mutant subunits. These hybrid channels would exhibit certain
conductance levels depending on the ratios of wild type and mutant
subunits and the structural characteristics of the channel pore. We
detected a total of 29 single channels, which can be separated into six
groups according to their single channel conductances. Of the 29 single channels detected, one exhibited an unitary conductance of 778 pS,
three 516 ± 4.3 pS, four 256 ± 14 pS, nine 176 ± 2.0 pS, eleven 60 ± 6.6 pS, and one 21 pS. All these single channels
were sensitive to EGTA and Ca2+ and were modified by
ryanodine (not shown). The 778- and 21-pS single channels probably
represent the homotetrameric wild type and mutant G4824A channels,
respectively, whereas single channels with intermediate unitary
conductances are most likely represent the wild type-mutant hybrid
channels. For example, the 516-pS conductance may be produced by a
hybrid channel with three wild type and one mutant subunits, while the
60-pS conductance may be generated by a hybrid channel with three
mutant and one wild type subunits. The 256- and 176-pS channels may be
formed by two wild type and two mutant subunits with different subunit
arrangements (Fig. 4a). It is
of interest that these intermediate conductances can not be derived
from a simple additive of the quarter conductance of the wild type
(798/4 pS) and mutant (22/4 pS) in any possible ratios for a tetramer.
Therefore, it is unlikely that the RyR channel conduction pathway is
formed by four individual pores from each RyR subunit. Conversely, the
glycines at position 4824 and the flanking residues of each monomer may
act cooperatively to form the conduction pathway or the ion selectivity
filter of the tetrameric RyR.
|
The equivalent region of other RyR isoforms (RyR1 and RyR3) and of
IP3Rs is most likely to be important in determining the single channel conductance. To examine this possibility, we have mutated G4729 in RyR3, corresponding to G4824 in mRyR2, to alanine. The
G4729A mutant RyR3 showed decreased caffeine-induced Ca2+
release and a drastic reduction in single channel conductance, but
retained [3H]ryanodine binding, similar to those observed
with the G4824A mutant mRyR2 (unpublished data). Recently, a mutation,
I4898T, in RyR1, corresponding to I4827 in mRyR2, has been reported to be associated with severe central core disease (28). Introduction of
this mutation into the rabbit RyR1 abolished
[3H]ryanodine binding and caffeine or halothane-induced
Ca2+ release in HEK293 cells transfected with the mutant
cDNA. Co-expression of the wild type and mutant RyR1 cDNA in a
1:1 ratio produced RyR channels with normal caffeine and halothane
sensitivities, but reduced levels of Ca2+ release and
[3H]ryanodine binding (28). One explanation for these
observations is that the I4849T mutation may disrupt the channel
conduction pathway (29). Mutations near this isoleucine in RyR1 have
also been reported to alter both [3H]ryanodine binding
and single channel conductance (30). Taken together, we propose that
this conserved region (GVRAGGGIGD) is likely to be the pore-forming
segment of RyR, and that the pore-forming segments of each subunit
constitute the RyR channel conduction pathway (Fig. 4b),
analogous to the K+ channel pore (26).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. John L. Sutko for the gift of the monoclonal antibody 34C, Dr. Jacques Barhanin for the gift of the mouse cardiac cDNA library, Dr. Wayne R. Giles and the Medical Research Council Group on Ion Channels and Transporters for continuous support, and Dr. Paul M. Schnetkamp for the use of his luminescence spectrometer.
| |
FOOTNOTES |
|---|
* This work was supported by research grants from the Medical Research Council of Canada and the Alberta Heritage Foundation for Medical Research (to S. R. W. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ These authors contributed equally to this study.
Scholar of the Alberta Heritage Foundation for Medical
Research (AHFMR). To whom correspondence should be addressed. Tel.: 403-220-4235; Fax: 403-283-4841; E-mail: swchen@ucalgary.ca.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RyRs, ryanodine receptors; IP3R, inositol 1,4,5-trisphosphate receptor; PCR, polymerase chain reaction; UTR, untranslated region; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; S, siemens.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berridge, M. J. (1993) Nature 361, 315-325[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Clapham, D. E. (1995) Cell 80, 259-268[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Coronado, R.,
Morrissette, J.,
Sukhareva, M.,
and Vaughan, D. M.
(1994)
Am. J. Physiol.
266,
C1485-C1504 |
| 4. | Meissner, G. (1994) Annu. Rev. Physiol. 56, 485-508[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Ogawa, Y. (1994) Crit. Rev. Biochem. Mol. Biol. 29, 229-274[Abstract] |
| 6. | Sorrentino, V. (1995) Adv. Pharmacol. 33, 67-90 |
| 7. |
Franzini-Armstrong, C.,
and Protasi, F.
(1997)
Physiol. Rev.
77,
699-729 |
| 8. |
Bhat, M. B.,
Zhao, J.,
Takeshima, H.,
and Ma, J.
(1997)
Biophys. J.
73,
1329-1336 |
| 9. |
Chen, S. R. W.,
Ebisawa, K.,
Li, X.,
and Zhang, L.
(1998)
J. Biol. Chem.
273,
14675-14678 |
| 10. | Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N., and Mikoshiba, K. (1989) Nature 342, 32-38[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Bezprozvanny, I.,
and Ehrlich, B. E.
(1994)
J. Gen. Physiol.
104,
821-856 |
| 12. |
Tinker, A.,
Lindsay, A. R. G.,
and Williams, A. J.
(1992)
J. Gen. Physiol.
100,
495-517 |
| 13. |
Mak, D.-O. D.,
and Foskett, J. K.
(1997)
J. Gen. Physiol.
109,
571-587 |
| 14. |
Michikawa, T.,
Hamanaka, H.,
Otsu, H.,
Yamamoto, A.,
Miyawaki, A.,
Furuichi, R.,
Tashiro, Y.,
and Mikoshiba, K.
(1994)
J. Biol. Chem.
269,
9184-9189 |
| 15. |
Zorzato, F.,
Fujii, J.,
Otsu, K.,
Phillips, M.,
Green, N. M.,
Lai, F. A.,
Meissner, G.,
and MacLennan, D. H.
(1990)
J. Biol. Chem.
265,
2244-2256 |
| 16. |
Airey, J. A.,
Beck, C. F.,
Murakami, K.,
Tanksley, S. J.,
Deerinck, T. J.,
Ellisman, M. H.,
and Sutko, J. L.
(1990)
J. Biol. Chem.
265,
14187-14194 |
| 17. | Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[Medline] [Order article via Infotrieve] |
| 18. | Nakai, J., Imagawa, T., Hakamata, Y., Shigekawa, M., Takeshima, H., and Numa, S. (1990) FEBS Lett. 271, 169-177[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Otsu, K.,
Willard, H. F.,
Khanna, V. K.,
Zorzato, F.,
Green, N. M.,
and MacLennan, D. H.
(1990)
J. Biol. Chem.
265,
13472-13483 |
| 20. | Tunwell, R. E. A., Wickenden, C., Bertrand, B. M. A., Shevchenko, V. I., Walsh, M. B., Allen, P. D., and Lai, F. A. (1996) Biochem. J. 318, 477-487 |
| 21. | Ho, S. N., Hunt, H. D., Morton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 51-59[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Du, G. G.,
Imredy, J. P.,
and MacLennan, D. H.
(1998)
J. Biol. Chem.
273,
33259-33266 |
| 23. |
Chen, S. R. W.,
Li, X.,
Ebisawa, K.,
and Zhang, L.
(1997)
J. Biol. Chem.
272,
24234-24246 |
| 24. | Fabiato, A., and Fabiato, F. (1979) J. Physiol. (Paris) 75, 463-505[Medline] [Order article via Infotrieve] |
| 25. |
Tanna, B.,
Welch, W.,
Ruest, L.,
Sutko, J. L.,
and Williams, A. J.
(1998)
J. Gen. Physiol.
112,
55-69 |
| 26. |
Doyle, D. A.,
Cabral, J. M.,
Pfeutzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and MacKinnon, R.
(1998)
Science
280,
69-77 |
| 27. |
MacKinnon, R.,
Cohen, S. L.,
Kuo, A.,
Lee, A.,
and Chait, B. T.
(1998)
Science
280,
106-109 |
| 28. |
Lynch, P. J.,
Tong, J.,
Lehane, M.,
Mallet, A.,
Giblin, L.,
Heffron, J. J. A.,
Vaughan, P.,
Zafra, G.,
MacLennan, D. H.,
and McCarthy, T. V.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4164-4169 |
| 29. |
Balshaw, D.,
Gao, L.,
and Meissner, G.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3345-3347 |
| 30. | Gao, L., Tripathy, A., Xu, L., Pasek, D., Balshaw, D., Xin, C., and Meissner, G. (1999) Biophys. J. 76, A303 (abstr.) |
This article has been cited by other articles:
![]() |
L. Xu, Y. Wang, N. Yamaguchi, D. A. Pasek, and G. Meissner Single Channel Properties of Heterotetrameric Mutant RyR1 Ion Channels Linked to Core Myopathies J. Biol. Chem., March 7, 2008; 283(10): 6321 - 6329. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Schug, P. C. A. da Fonseca, C. D. Bhanumathy, L. Wagner II, X. Zhang, B. Bailey, E. P. Morris, D. I. Yule, and S. K. Joseph Molecular Characterization of the Inositol 1,4,5-Trisphosphate Receptor Pore-forming Segment J. Biol. Chem., February 1, 2008; 283(5): 2939 - 2948. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wang, W. Chen, S. Cai, J. Zhang, J. Bolstad, T. Wagenknecht, Z. Liu, and S. R. W. Chen Localization of an NH2-terminal Disease-causing Mutation Hot Spot to the "Clamp" Region in the Three-dimensional Structure of the Cardiac Ryanodine Receptor J. Biol. Chem., June 15, 2007; 282(24): 17785 - 17793. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak Inositol Trisphosphate Receptor Ca2+ Release Channels Physiol Rev, April 1, 2007; 87(2): 593 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wu, M C. A. Ibarra, M. C. V. Malicdan, K. Murayama, Y. Ichihara, H. Kikuchi, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino Central core disease is due to RYR1 mutations in more than 90% of patients Brain, June 1, 2006; 129(6): 1470 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xu, Y. Wang, D. Gillespie, and G. Meissner Two Rings of Negative Charges in the Cytosolic Vestibule of Type-1 Ryanodine Receptor Modulate Ion Fluxes Biophys. J., January 15, 2006; 90(2): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, R. Wang, J. Zhang, S. R. W. Chen, and T. Wagenknecht Localization of a Disease-associated Mutation Site in the Three-dimensional Structure of the Cardiac Muscle Ryanodine Receptor J. Biol. Chem., November 11, 2005; 280(45): 37941 - 37947. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Ranatunga, T. M. Moreno-King, B. Tanna, R. Wang, S. R. W. Chen, L. Ruest, W. Welch, and A. J. Williams The Gln4863Ala Mutation within a Putative, Pore-Lining Trans-Membrane Helix of the Cardiac Ryanodine Receptor Channel Alters Both the Kinetics of Ryanoid Interaction and the Subsequent Fractional Conductance Mol. Pharmacol., September 1, 2005; 68(3): 840 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, L. Xu, D. A. Pasek, D. Gillespie, and G. Meissner Probing the Role of Negatively Charged Amino Acid Residues in Ion Permeation of Skeletal Muscle Ryanodine Receptor Biophys. J., July 1, 2005; 89(1): 256 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brini, S. Manni, N. Pierobon, G. G. Du, P. Sharma, D. H. MacLennan, and E. Carafoli Ca2+ Signaling in HEK-293 and Skeletal Muscle Cells Expressing Recombinant Ryanodine Receptors Harboring Malignant Hyperthermia and Central Core Disease Mutations J. Biol. Chem., April 15, 2005; 280(15): 15380 - 15389. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Welch, S. Rheault, D. J. West, and A. J. Williams A Model of the Putative Pore Region of the Cardiac Ryanodine Receptor Channel Biophys. J., October 1, 2004; 87(4): 2335 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srikanth, Z. Wang, H. Tu, S. Nair, M. K. Mathew, G. Hasan, and I. Bezprozvanny Functional Properties of the Drosophila melanogaster Inositol 1,4,5-Trisphosphate Receptor Mutants Biophys. J., June 1, 2004; 86(6): 3634 - 3646. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. George, H. Jundi, N. L. Thomas, M. Scoote, N. Walters, A. J. Williams, and F. A. Lai Ryanodine Receptor Regulation by Intramolecular Interaction between Cytoplasmic and Transmembrane Domains Mol. Biol. Cell, June 1, 2004; 15(6): 2627 - 2638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lee, S.-H. Rho, D. W. Shin, C. Cho, W. J. Park, S. H. Eom, J. Ma, and D. H. Kim Negatively Charged Amino Acids within the Intraluminal Loop of Ryanodine Receptor Are Involved in the Interaction with Triadin J. Biol. Chem., February 20, 2004; 279(8): 6994 - 7000. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wang, J. Bolstad, H. Kong, L. Zhang, C. Brown, and S. R. W. Chen The Predicted TM10 Transmembrane Sequence of the Cardiac Ca2+ Release Channel (Ryanodine Receptor) Is Crucial for Channel Activation and Gating J. Biol. Chem., January 30, 2004; 279(5): 3635 - 3642. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wang, L. Zhang, J. Bolstad, N. Diao, C. Brown, L. Ruest, W. Welch, A. J. Williams, and S. R. W. Chen Residue Gln4863 within a Predicted Transmembrane Sequence of the Ca2+ Release Channel (Ryanodine Receptor) Is Critical for Ryanodine Interaction J. Biol. Chem., December 19, 2003; 278(51): 51557 - 51565. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Anyatonwu, E. D. Buck, and B. E. Ehrlich Methanethiosulfonate Ethylammonium Block of Amine Currents through the Ryanodine Receptor Reveals Single Pore Architecture J. Biol. Chem., November 14, 2003; 278(46): 45528 - 45538. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Romero, N. Monnier, L. Viollet, A. Cortey, M. Chevallay, J. P. Leroy, J. Lunardi, and M. Fardeau Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia Brain, November 1, 2003; 126(11): 2341 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fessenden, C. F. Perez, S. Goth, I. N. Pessah, and P. D. Allen Identification of a Key Determinant of Ryanodine Receptor Type 1 Required for Activation by 4-Chloro-m-cresol J. Biol. Chem., August 1, 2003; 278(31): 28727 - 28735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, Z. Liu, H. Masumiya, R. Wang, D. Jiang, F. Li, T. Wagenknecht, and S. R. W. Chen Three-dimensional Localization of Divergent Region 3 of the Ryanodine Receptor to the Clamp-shaped Structures Adjacent to the FKBP Binding Sites J. Biol. Chem., April 11, 2003; 278(16): 14211 - 14218. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Bidasee, L. Xu, G. Meissner, and H. R. Besch Jr. Diketopyridylryanodine Has Three Concentration-dependent Effects on the Cardiac Calcium-release Channel/Ryanodine Receptor J. Biol. Chem., April 11, 2003; 278(16): 14237 - 14248. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Du, B. Sandhu, V. K. Khanna, X. H. Guo, and D. H. MacLennan Topology of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum (RyR1) PNAS, December 24, 2002; 99(26): 16725 - 16730. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, J. Zhang, P. Li, S. R. W. Chen, and T. Wagenknecht Three-dimensional Reconstruction of the Recombinant Type 2 Ryanodine Receptor and Localization of Its Divergent Region 1 J. Biol. Chem., November 22, 2002; 277(48): 46712 - 46719. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xiao, H. Masumiya, D. Jiang, R. Wang, Y. Sei, L. Zhang, T. Murayama, Y. Ogawa, F. A. Lai, T. Wagenknecht, et al. Isoform-dependent Formation of Heteromeric Ca2+ Release Channels (Ryanodine Receptors) J. Biol. Chem., October 25, 2002; 277(44): 41778 - 41785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fill and J. A. Copello Ryanodine Receptor Calcium Release Channels Physiol Rev, October 1, 2002; 82(4): 893 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Baker, I. I. Serysheva, S. Sencer, Y. Wu, S. J. Ludtke, W. Jiang, S. L. Hamilton, and W. Chiu The skeletal muscle Ca2+ release channel has an oxidoreductase-like domain PNAS, September 17, 2002; 99(19): 12155 - 12160. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Shah and R. Sowdhamini Structural understanding of the transmembrane domains of inositol triphosphate receptors and ryanodine receptors towards calcium channeling Protein Eng. Des. Sel., November 1, 2001; 14(11): 867 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Masumiya, P. Li, L. Zhang, and S. R. W. Chen Ryanodine Sensitizes the Ca2+ Release Channel (Ryanodine Receptor) to Ca2+ Activation J. Biol. Chem., October 19, 2001; 276(43): 39727 - 39735. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Monnier, N. B. Romero, J. Lerale, P. Landrieu, Y. Nivoche, M. Fardeau, and J. Lunardi Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor Hum. Mol. Genet., October 1, 2001; 10(22): 2581 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Avila, J. J. O'Brien, and R. T. Dirksen Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor PNAS, March 27, 2001; 98(7): 4215 - 4220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suko, G. Hellmann, and H. Drobny Short- and Long-Term Functional Alterations of the Skeletal Muscle Calcium Release Channel (Ryanodine Receptor) by Suramin: Apparent Dissociation of Single Channel Current Recording and [3H]Ryanodine Binding Mol. Pharmacol., March 1, 2001; 59(3): 543 - 556. [Abstract] [Full Text] |
||||
![]() |
P. J. Laitinen, K. M. Brown, K. Piippo, H. Swan, J. M. Devaney, B. Brahmbhatt, E. A. Donarum, M. Marino, N. Tiso, M. Viitasalo, et al. Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia Circulation, January 30, 2001; 103(4): 485 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Du, V. K. Khanna, and D. H. MacLennan Mutation of Divergent Region 1 Alters Caffeine and Ca2+ Sensitivity of the Skeletal Muscle Ca2+ Release Channel (Ryanodine Receptor) J. Biol. Chem., April 14, 2000; 275(16): 11778 - 11783. [Abstract] [Full Text] [PDF] |
||||
![]() |
|